AKT1 and hepatocellular carcinoma: Treatment of EGCG resulted in promoted apoptosis in human breast cancer T47D cells, pancreatic cancer PANC-1 cells and hepatocellular carcinoma SMMC7721 cells through modulation of PI3K/AKT signaling [29–31].